Novo Biosciences

About:

Novo Biosciences develops cardiac drugs designed to reverse the life-threatening damage caused by heart attacks.

Website: https://novobiosciences.com/

Top Investors: National Institutes of Health, Maine Technology Institute

Description:

Novo Biosciences develops cardiac drugs designed to reverse the life-threatening damage caused by heart attacks. Its drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in genes, enabling patients to regenerate damaged organs and tissues and live a healthier life. The company was founded in 2013 and is headquartered in Bar Harbor, Maine.